Pharmabiz2m
INmune Bio to submit BLA with US FDA seeking approval of CORDStrom to treat recessive dystrophic epidermolysis bullosa in paediatric patients
INmune Bio, Inc, a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, has announced the following a ...
Pharmabiz32m
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures: Our Bureau, Bengaluru Wednesday, February 12, 2025, 15:30 Hr ...
Pharmabiz2h
Researchers find influenza A viruses adapt shape in response to environmental pressures
Researchers find influenza A viruses adapt shape in response to environmental pressures: Bethesda, Maryland Wednesday, February 12, 2025, 14:00 Hrs [IST] Influenza A virus particl ...
Pharmabiz3h
EMA establishes regular procedure for scientific advice on certain high-risk medical devices
EMA establishes regular procedure for scientific advice on certain high-risk medical devices: Amsterdam, The Netherlands Wednesday, February 12, 2025, 13:00 Hrs [IST] EMA, in clos ...
Pharmabiz3h
Glenmark Pharma ceuticals Inc., USA introduces clindamycin phosphate foam, 1%
Glenmark Pharma ceuticals Inc., USA introduces clindamycin phosphate foam, 1%: Our Bureau, Mumbai Wednesday, February 12, 2025, 12:30 Hrs [IST] Glenmark Pharmaceuticals Inc., USA ...
Pharmabiz4h
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...
Pharmabiz5h
National Organization for Rare Disorders issues new report on lifesaving newborn screening programmes
National Organization for Rare Disorders issues new report on lifesaving newborn screening programmes: Washington, D.C. Wednesday, February 12, 2025, 11:00 Hrs [IST] The National ...
Pharmabiz7h
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...
Pharmabiz8h
Pharmexcil announces business delegation to Zambia, Tanzania & DR Congo from March 24 to April 1
Pharmexcil announces business delegation to Zambia, Tanzania & DR Congo from March 24 to April 1: Shardul Nautiyal, Mumbai Wednesday, February 12, 2025, 08:00 Hrs [IST] The Pharma ...
Pharmabiz8h
Indian healthcare industry keen on paving way for accessible & scalable precision medicine
Indian healthcare industry keen on paving way for accessible & scalable precision medicine: Nandita Vijayasimha, Bengaluru Wednesday, February 12, 2025, 08:00 Hrs [IST] Indian hea ...
Pharmabiz8h
NPPA asks online pharmacies to comply with DPCO provisions of price list display
NPPA asks online pharmacies to comply with DPCO provisions of price list display: Our Bureau, New Delhi Wednesday, February 12, 2025, 08:00 Hrs [IST] The National Pharmaceutical P ...
Pharmabiz8h
Health ministry issues final notification on extension of revised Schedule M deadline for MSMEs
The Union ministry of health and family welfare has issued the final notification extending the deadline for implementation of the revised Schedule M manufacturing standards to one more year for the ...